-
1
-
-
9644283089
-
Global data on visual impairment in the year 2002
-
Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82(11): 844-851.
-
(2004)
Bull World Health Organ
, vol.82
, Issue.11
, pp. 844-851
-
-
Resnikoff, S.1
Pascolini, D.2
Etya'ale, D.3
Kocur, I.4
Pararajasegaram, R.5
Pokharel, G.P.6
-
2
-
-
0031752685
-
Global burden of diabetes 1995-2025: Prevalence, numerical estimates, and projections
-
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-1431.
-
(1998)
Diabetes Care
, vol.21
, Issue.9
, pp. 1414-1431
-
-
King, H.1
Aubert, R.E.2
Herman, W.H.3
-
3
-
-
84895832615
-
Global estimates of diabetes prevalence for 2013 and projections for 2035
-
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103(2): 137-149.
-
(2014)
Diabetes Res Clin Pract
, vol.103
, Issue.2
, pp. 137-149
-
-
Guariguata, L.1
Whiting, D.R.2
Hambleton, I.3
Beagley, J.4
Linnenkamp, U.5
Shaw, J.E.6
-
4
-
-
0030280257
-
Serum lipids and diabetic retinopathy early treatment diabetic retinopathy study research group
-
Ferris 3rd FL, Chew EY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996; 19(11): 1291-1293.
-
(1996)
Diabetes Care
, vol.19
, Issue.11
, pp. 1291-1293
-
-
Ferris, F.L.1
Chew, E.Y.2
Hoogwerf, B.J.3
-
5
-
-
0036145097
-
The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study
-
Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, Gottdiener JS, et al. The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 2002; 86(1): 84-90.
-
(2002)
Br J Ophthalmol
, vol.86
, Issue.1
, pp. 84-90
-
-
Klein, R.1
Marino, E.K.2
Kuller, L.H.3
Polak, J.F.4
Tracy, R.P.5
Gottdiener, J.S.6
-
6
-
-
0021850016
-
Diabetic choroidopathy Light and electron microscopic observations of seven cases
-
Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 1985; 92(4): 512-522.
-
(1985)
Ophthalmology
, vol.92
, Issue.4
, pp. 512-522
-
-
Hidayat, A.A.1
Fine, B.S.2
-
7
-
-
0024789889
-
Diabetic choroidal and iris vasculature scanning electron microscopy findings
-
Fryczkowski AW, Hodes BL, Walker J. Diabetic choroidal and iris vasculature scanning electron microscopy findings. Int Ophthalmol 1989; 13(4): 269-279.
-
(1989)
Int Ophthalmol
, vol.13
, Issue.4
, pp. 269-279
-
-
Fryczkowski, A.W.1
Hodes, B.L.2
Walker, J.3
-
8
-
-
0022362986
-
Ten years experience with choroidal angiography using indocyanine green dye: A new routine examination or an epilogue?
-
Bischoff PM, Flower RW. Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue?. Doc Ophthalmol 1985; 60(3): 235-291.
-
(1985)
Doc Ophthalmol
, vol.60
, Issue.3
, pp. 235-291
-
-
Bischoff, P.M.1
Flower, R.W.2
-
9
-
-
0032959221
-
Peripheral choriovitreal neovascularization in proliferative diabetic retinopathy: Histopathologic and ultrastructural study
-
Ishibashi T, Murata T, Kohno T, Ohnishi Y, Inomata H. Peripheral choriovitreal neovascularization in proliferative diabetic retinopathy: histopathologic and ultrastructural study. Ophthalmologica 1999; 213(3): 154-158.
-
(1999)
Ophthalmologica
, vol.213
, Issue.3
, pp. 154-158
-
-
Ishibashi, T.1
Murata, T.2
Kohno, T.3
Ohnishi, Y.4
Inomata, H.5
-
10
-
-
0041358796
-
Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies
-
Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003; 26(9): 2653-2664.
-
(2003)
Diabetes Care
, vol.26
, Issue.9
, pp. 2653-2664
-
-
Ciulla, T.A.1
Amador, A.G.2
Zinman, B.3
-
11
-
-
1542603184
-
Potential new strategies to prevent the development of diabetic retinopathy
-
Mohr S. Potential new strategies to prevent the development of diabetic retinopathy. Expert Opin Investig Drugs 2004; 13(3): 189-198.
-
(2004)
Expert Opin Investig Drugs
, vol.13
, Issue.3
, pp. 189-198
-
-
Mohr, S.1
-
12
-
-
0033400348
-
Pathogenetic potential of leukocytes in diabetic retinopathy
-
Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol 1999; 14(4): 233-239.
-
(1999)
Semin Ophthalmol
, vol.14
, Issue.4
, pp. 233-239
-
-
Miyamoto, K.1
Ogura, Y.2
-
13
-
-
33747203244
-
Diabetic retinopathy: The latest in current management
-
Suppl
-
Bhavsar AR. Diabetic retinopathy: the latest in current management. Retina 2006; 26(6 Suppl): S71-S79.
-
(2006)
Retina
, vol.26
, Issue.6
, pp. S71-S79
-
-
Bhavsar, A.R.1
-
14
-
-
33747188100
-
25 years of progress in the treatment of retinal diseases: Where we have been, where we are now, and where we will be
-
Suppl
-
Bhavsar AR, Tornambe PE. 25 years of progress in the treatment of retinal diseases: where we have been, where we are now, and where we will be. Retina 2006; 26(6 Suppl): S1-S6.
-
(2006)
Retina
, vol.26
, Issue.6
, pp. S1-S6
-
-
Bhavsar, A.R.1
Tornambe, P.E.2
-
15
-
-
0031793875
-
The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII.
-
Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105(10): 1801-1815.
-
(1998)
Ophthalmology
, vol.105
, Issue.10
, pp. 1801-1815
-
-
Klein, R.1
Klein, B.E.2
Moss, S.E.3
Cruickshanks, K.J.4
-
16
-
-
58449114090
-
Diabetic macular edema: Pathogenesis and treatment
-
Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009; 54(1): 1-32.
-
(2009)
Surv Ophthalmol
, vol.54
, Issue.1
, pp. 1-32
-
-
Bhagat, N.1
Grigorian, R.A.2
Tutela, A.3
Zarbin, M.A.4
-
17
-
-
84876729820
-
Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
-
Klaassen I, Van Noorden CJ, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 2013; 34: 19-48.
-
(2013)
Prog Retin Eye Res
, vol.34
, pp. 19-48
-
-
Klaassen, I.1
Van Noorden, C.J.2
Schlingemann, R.O.3
-
18
-
-
57549102804
-
Etiology and treatment of macular edema
-
e11
-
Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol 2009; 147(1): 11-21 e11.
-
(2009)
Am J Ophthalmol
, vol.147
, Issue.1
, pp. 11-21
-
-
Johnson, M.W.1
-
19
-
-
7044228789
-
A central role for inflammation in the pathogenesis of diabetic retinopathy
-
Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18(12): 1450-1452.
-
(2004)
FASEB J
, vol.18
, Issue.12
, pp. 1450-1452
-
-
Joussen, A.M.1
Poulaki, V.2
Le, M.L.3
Koizumi, K.4
Esser, C.5
Janicki, H.6
-
20
-
-
33847765812
-
Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products
-
Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 2007; 48(2): 858-865.
-
(2007)
Invest Ophthalmol Vis Sci
, vol.48
, Issue.2
, pp. 858-865
-
-
Kaji, Y.1
Usui, T.2
Ishida, S.3
Yamashiro, K.4
Moore, T.C.5
Moore, J.6
-
21
-
-
33846925850
-
Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: Impaired permeability and angiogenesis in eNOS-deficient mice
-
Min JK, Cho YL, Choi JH, Kim Y, Kim JH, Yu YS, et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007; 109(4): 1495-1502.
-
(2007)
Blood
, vol.109
, Issue.4
, pp. 1495-1502
-
-
Min, J.K.1
Cho, Y.L.2
Choi, J.H.3
Kim, Y.4
Kim, J.H.5
Yu, Y.S.6
-
22
-
-
0036510762
-
TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells
-
Kim YM, Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, et al. TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002; 277(9): 6799-6805.
-
(2002)
J Biol Chem
, vol.277
, Issue.9
, pp. 6799-6805
-
-
Kim, Y.M.1
Kim, Y.M.2
Lee, Y.M.3
Kim, H.S.4
Kim, J.D.5
Choi, Y.6
-
23
-
-
33745674107
-
Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics
-
Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, et al. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest Ophthalmol Vis Sci 2006; 47(6): 2701-2708.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, Issue.6
, pp. 2701-2708
-
-
Clermont, A.C.1
Cahill, M.2
Salti, H.3
Rook, S.L.4
Rask-Madsen, C.5
Goddard, L.6
-
24
-
-
0025944878
-
The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms
-
Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3(9): 347-350.
-
(1991)
Cancer Cells
, vol.3
, Issue.9
, pp. 347-350
-
-
Haynes, B.F.1
Liao, H.X.2
Patton, K.L.3
-
25
-
-
0029938495
-
Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro
-
Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 1996; 66(5): 664-668.
-
(1996)
Int J Cancer
, vol.66
, Issue.5
, pp. 664-668
-
-
Trochon, V.1
Mabilat, C.2
Bertrand, P.3
Legrand, Y.4
Smadja-Joffe, F.5
Soria, C.6
-
26
-
-
0029088742
-
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
-
Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96(3): 1395-1403.
-
(1995)
J Clin Invest
, vol.96
, Issue.3
, pp. 1395-1403
-
-
Schmidt, A.M.1
Hori, O.2
Chen, J.X.3
Li, J.F.4
Crandall, J.5
Zhang, J.6
-
27
-
-
0346406983
-
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB Prospective Complications Study
-
Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003; 26(7): 2165-2173.
-
(2003)
Diabetes Care
, vol.26
, Issue.7
, pp. 2165-2173
-
-
Schram, M.T.1
Chaturvedi, N.2
Schalkwijk, C.3
Giorgino, F.4
Ebeling, P.5
Fuller, J.H.6
-
28
-
-
0036216417
-
Is diabetic retinopathy an inflammatory disease?
-
Adamis AP. Is diabetic retinopathy an inflammatory disease?. Br J Ophthalmol 2002; 86(4): 363-365.
-
(2002)
Br J Ophthalmol
, vol.86
, Issue.4
, pp. 363-365
-
-
Adamis, A.P.1
-
29
-
-
0022347471
-
Photocoagulation for diabetic macular edema early treatment diabetic retinopathy study report number 1 early treatment diabetic retinopathy study research group
-
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103(12): 1796-1806.
-
(1985)
Arch Ophthalmol
, vol.103
, Issue.12
, pp. 1796-1806
-
-
-
30
-
-
0023202345
-
Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema
-
Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group
-
Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987; 94(7): 761-774.
-
(1987)
Ophthalmology
, vol.94
, Issue.7
, pp. 761-774
-
-
-
31
-
-
0026324005
-
Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-Term visual results
-
Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-Term visual results. Ophthalmology 1991; 98(10): 1594-1602.
-
(1991)
Ophthalmology
, vol.98
, Issue.10
, pp. 1594-1602
-
-
Lee, C.M.1
Olk, R.J.2
-
32
-
-
0026075103
-
Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema
-
Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 1991; 109(11): 1549-1551.
-
(1991)
Arch Ophthalmol
, vol.109
, Issue.11
, pp. 1549-1551
-
-
Schatz, H.1
Madeira, D.2
McDonald, H.R.3
Johnson, R.N.4
-
33
-
-
0027225583
-
Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema
-
Rutledge BK, Wallow IH, Poulsen GL. Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol 1993; 111(5): 608-613.
-
(1993)
Arch Ophthalmol
, vol.111
, Issue.5
, pp. 608-613
-
-
Rutledge, B.K.1
Wallow, I.H.2
Poulsen, G.L.3
-
34
-
-
34247164981
-
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema
-
Writing Committee for the Diabetic Retinopathy Clinical Research N.
-
Writing Committee for the Diabetic Retinopathy Clinical Research N, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007; 125(4): 469-480.
-
(2007)
Arch Ophthalmol
, vol.125
, Issue.4
, pp. 469-480
-
-
Fong, D.S.1
Strauber, S.F.2
Aiello, L.P.3
Beck, R.W.4
Callanan, D.G.5
-
35
-
-
84883237476
-
Subthreshold laser therapy for diabetic macular edema: Metabolic and safety issues
-
Vujosevic S, Martini F, Convento E, Longhin E, Kotsafti O, Parrozzani R, et al. Subthreshold laser therapy for diabetic macular edema: Metabolic and safety issues Curr Med Chem 2013; 20(26): 3267-3271.
-
(2013)
Curr Med Chem
, vol.20
, Issue.26
, pp. 3267-3271
-
-
Vujosevic, S.1
Martini, F.2
Convento, E.3
Longhin, E.4
Kotsafti, O.5
Parrozzani, R.6
-
36
-
-
79953299899
-
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
-
Elman MJ, Bressler NM, Qin H, Beck RW, Ferris III FL, Friedman SM, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011; 118(4): 609-614.
-
(2011)
Ophthalmology
, vol.118
, Issue.4
, pp. 609-614
-
-
Elman, M.J.1
Bressler, N.M.2
Qin, H.3
Beck, R.W.4
Ferris, F.L.5
Friedman, S.M.6
-
37
-
-
79251606719
-
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): A 12-month randomized controlled double-masked multicenter phase II study
-
Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010; 33(11): 2399-2405.
-
(2010)
Diabetes Care
, vol.33
, Issue.11
, pp. 2399-2405
-
-
Massin, P.1
Bandello, F.2
Garweg, J.G.3
Hansen, L.L.4
Harding, S.P.5
Larsen, M.6
-
38
-
-
79953311138
-
The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
-
Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118(4): 615-625.
-
(2011)
Ophthalmology
, vol.118
, Issue.4
, pp. 615-625
-
-
Mitchell, P.1
Bandello, F.2
Schmidt-Erfurth, U.3
Lang, G.E.4
Massin, P.5
Schlingemann, R.O.6
-
39
-
-
84863401792
-
Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE
-
Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119(4): 789-801.
-
(2012)
Ophthalmology
, vol.119
, Issue.4
, pp. 789-801
-
-
Nguyen, Q.D.1
Brown, D.M.2
Marcus, D.M.3
Boyer, D.S.4
Patel, S.5
Feiner, L.6
-
40
-
-
84865593623
-
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: Report 3
-
Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 2012; 130(8): 972-979.
-
(2012)
Arch Ophthalmol
, vol.130
, Issue.8
, pp. 972-979
-
-
Rajendram, R.1
Fraser-Bell, S.2
Kaines, A.3
Michaelides, M.4
Hamilton, R.D.5
Esposti, S.D.6
-
41
-
-
84908897529
-
Intravitreal aflibercept for diabetic macular edema
-
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, et al. Intravitreal Aflibercept for Diabetic Macular Edema. Ophthalmology 2014; 121(11): 2247-2254.
-
(2014)
Ophthalmology
, vol.121
, Issue.11
, pp. 2247-2254
-
-
Korobelnik, J.F.1
Do, D.V.2
Schmidt-Erfurth, U.3
Boyer, D.S.4
Holz, F.G.5
Heier, J.S.6
-
42
-
-
33947275043
-
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema
-
Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007; 125(3): 309-317.
-
(2007)
Arch Ophthalmol
, vol.125
, Issue.3
, pp. 309-317
-
-
Kuppermann, B.D.1
Blumenkranz, M.S.2
Haller, J.A.3
Williams, G.A.4
Weinberg, D.V.5
Chou, C.6
-
43
-
-
77952779304
-
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
-
Diabetic Retinopathy Clinical Research N. e1035
-
Diabetic Retinopathy Clinical Research N, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010; 117(6): 1064-1077 e1035.
-
(2010)
Ophthalmology
, vol.117
, Issue.6
, pp. 1064-1077
-
-
Elman, M.J.1
Aiello, L.P.2
Beck, R.W.3
Bressler, N.M.4
Bressler, S.B.5
-
44
-
-
79955558683
-
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients
-
Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011; 31(5): 915-923.
-
(2011)
Retina
, vol.31
, Issue.5
, pp. 915-923
-
-
Boyer, D.S.1
Faber, D.2
Gupta, S.3
Patel, S.S.4
Tabandeh, H.5
Li, X.Y.6
-
45
-
-
84908118639
-
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
-
Boyer DS, Yoon YH, Belfort Jr. R, Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 2014; 121(10): 1904-1914.
-
(2014)
Ophthalmology
, vol.121
, Issue.10
, pp. 1904-1914
-
-
Boyer, D.S.1
Yoon, Y.H.2
Belfort, R.3
Bandello, F.4
Maturi, R.K.5
Augustin, A.J.6
-
46
-
-
79961044911
-
Fluocinolone acetonide intravitreal implant for diabetic macular edema: A 3-year multicenter randomized controlled clinical trial
-
Pearson PA, Comstock TL, Ip M, Callanan D, Morse LS, Ashton P, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology 2011; 118(8): 1580-1587.
-
(2011)
Ophthalmology
, vol.118
, Issue.8
, pp. 1580-1587
-
-
Pearson, P.A.1
Comstock, T.L.2
Ip, M.3
Callanan, D.4
Morse, L.S.5
Ashton, P.6
-
47
-
-
79953329178
-
Long-Term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema
-
e622
-
Campochiaro PA, Brown DM, Pearson A, Ciulla T, Boyer D, Holz FG, et al. Long-Term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology 2011; 118(4): 626-635 e622.
-
(2011)
Ophthalmology
, vol.118
, Issue.4
, pp. 626-635
-
-
Campochiaro, P.A.1
Brown, D.M.2
Pearson, A.3
Ciulla, T.4
Boyer, D.5
Holz, F.G.6
-
48
-
-
33747623255
-
Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebocontrolled, randomized clinical trial
-
Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebocontrolled, randomized clinical trial. Ophthalmology 2006; 113 (9): 1533-1538.
-
(2006)
Ophthalmology
, vol.113
, Issue.9
, pp. 1533-1538
-
-
Gillies, M.C.1
Sutter, F.K.2
Simpson, J.M.3
Larsson, J.4
Ali, H.5
Zhu, M.6
-
49
-
-
27644557312
-
Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy
-
Munir WM, Pulido JS, Sharma MC, Buerk BM. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 2005; 40(5): 598-604.
-
(2005)
Can J Ophthalmol
, vol.40
, Issue.5
, pp. 598-604
-
-
Munir, W.M.1
Pulido, J.S.2
Sharma, M.C.3
Buerk, B.M.4
-
50
-
-
77749330682
-
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema
-
Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C, et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010; 128(3): 289-296.
-
(2010)
Arch Ophthalmol
, vol.128
, Issue.3
, pp. 289-296
-
-
Haller, J.A.1
Kuppermann, B.D.2
Blumenkranz, M.S.3
Williams, G.A.4
Weinberg, D.V.5
Chou, C.6
-
51
-
-
77952148791
-
Intravitreous dexamethasone effects on different patterns of diabetic macular edema
-
Kuppermann BD, Chou C, Weinberg DV, Whitcup SM, Haller JA, Blumenkranz MS, et al. Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol 2010; 128(5): 642-643.
-
(2010)
Arch Ophthalmol
, vol.128
, Issue.5
, pp. 642-643
-
-
Kuppermann, B.D.1
Chou, C.2
Weinberg, D.V.3
Whitcup, S.M.4
Haller, J.A.5
Blumenkranz, M.S.6
-
52
-
-
84868208071
-
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results
-
Diabetic Retinopathy Clinical Research N.
-
Diabetic Retinopathy Clinical Research N, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 2012; 119(11): 2312-2318.
-
(2012)
Ophthalmology
, vol.119
, Issue.11
, pp. 2312-2318
-
-
Elman, M.J.1
Qin, H.2
Aiello, L.P.3
Beck, R.W.4
Bressler, N.M.5
-
53
-
-
25844513658
-
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
-
Cunningham Jr. ET, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112(10): 1747-1757.
-
(2005)
Ophthalmology
, vol.112
, Issue.10
, pp. 1747-1757
-
-
Cunningham, E.T.1
Adamis, A.P.2
Altaweel, M.3
Aiello, L.P.4
Bressler, N.M.5
D'Amico, D.J.6
-
54
-
-
79958012399
-
A phase 2/3, multicenter, randomized, doublemasked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema
-
Macugen Study G.
-
Sultan MB, Zhou D, Loftus J, Dombi T, Ice KSMacugen Study G. A phase 2/3, multicenter, randomized, doublemasked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 2011; 118(6): 1107-1118.
-
(2011)
Ophthalmology
, vol.118
, Issue.6
, pp. 1107-1118
-
-
Sultan, M.B.1
Zhou, D.2
Loftus, J.3
Dombi, T.4
Ice, K.S.5
-
55
-
-
77952889192
-
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: Report 2
-
e1072
-
Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 2010; 117(6): 1078-1086 e1072.
-
(2010)
Ophthalmology
, vol.117
, Issue.6
, pp. 1078-1086
-
-
Michaelides, M.1
Kaines, A.2
Hamilton, R.D.3
Fraser-Bell, S.4
Rajendram, R.5
Quhill, F.6
-
56
-
-
67650043196
-
Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: Six-month results of a randomized controlled trial
-
Lam DS, Lai TY, Lee VY, Chan CK, Liu DT, Mohamed S, et al. Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial. Retina 2009; 29(3): 292-299.
-
(2009)
Retina
, vol.29
, Issue.3
, pp. 292-299
-
-
Lam, D.S.1
Lai, T.Y.2
Lee, V.Y.3
Chan, C.K.4
Liu, D.T.5
Mohamed, S.6
-
57
-
-
50249139773
-
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: Baseline features
-
Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, et al. A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina 2008; 28(7): 919-930.
-
(2008)
Retina
, vol.28
, Issue.7
, pp. 919-930
-
-
Ip, M.S.1
Bressler, S.B.2
Antoszyk, A.N.3
Flaxel, C.J.4
Kim, J.E.5
Friedman, S.M.6
-
58
-
-
50249149459
-
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
-
Diabetic Retinopathy Clinical Research N. 1449 e1441-1410
-
Diabetic Retinopathy Clinical Research N. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008; 115(9): 1447-1449 1449 e1441-1410.
-
(2008)
Ophthalmology
, vol.115
, Issue.9
, pp. 1447-1449
-
-
-
59
-
-
62449171859
-
Threeyear follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema
-
Diabetic Retinopathy Clinical Research N.
-
Diabetic Retinopathy Clinical Research N, Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, et al. Threeyear follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009; 127(3): 245-251.
-
(2009)
Arch Ophthalmol
, vol.127
, Issue.3
, pp. 245-251
-
-
Beck, R.W.1
Edwards, A.R.2
Aiello, L.P.3
Bressler, N.M.4
Ferris, F.5
-
60
-
-
84922192847
-
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: The bevordex study
-
Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J, et al. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: The BEVORDEX Study. Ophthalmology 2014; 121 (12): 2473-2481.
-
(2014)
Ophthalmology
, vol.121
, Issue.12
, pp. 2473-2481
-
-
Gillies, M.C.1
Lim, L.L.2
Campain, A.3
Quin, G.J.4
Salem, W.5
Li, J.6
-
61
-
-
0032819686
-
The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes
-
Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999; 40(9): 1891-1898.
-
(1999)
Invest Ophthalmol Vis Sci
, vol.40
, Issue.9
, pp. 1891-1898
-
-
Oh, H.1
Takagi, H.2
Takagi, C.3
Suzuma, K.4
Otani, A.5
Ishida, K.6
-
62
-
-
0033888525
-
Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia
-
Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000; 156(6): 2077-2089.
-
(2000)
Am J Pathol
, vol.156
, Issue.6
, pp. 2077-2089
-
-
Mandriota, S.J.1
Pyke, C.2
Di Sanza, C.3
Quinodoz, P.4
Pittet, B.5
Pepper, M.S.6
-
63
-
-
12144286666
-
Angiopoietin-2 causes pericyte dropout in the normal retina: Evidence for involvement in diabetic retinopathy
-
Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004; 53(4): 1104-1110.
-
(2004)
Diabetes
, vol.53
, Issue.4
, pp. 1104-1110
-
-
Hammes, H.P.1
Lin, J.2
Wagner, P.3
Feng, Y.4
Vom Hagen, F.5
Krzizok, T.6
-
64
-
-
35649026775
-
High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A
-
Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007; 282(42): 31038-31045.
-
(2007)
J Biol Chem
, vol.282
, Issue.42
, pp. 31038-31045
-
-
Yao, D.1
Taguchi, T.2
Matsumura, T.3
Pestell, R.4
Edelstein, D.5
Giardino, I.6
-
65
-
-
2542453735
-
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies
-
Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103(11): 4150-4156.
-
(2004)
Blood
, vol.103
, Issue.11
, pp. 4150-4156
-
-
Fiedler, U.1
Scharpfenecker, M.2
Koidl, S.3
Hegen, A.4
Grunow, V.5
Schmidt, J.M.6
-
66
-
-
16244402264
-
Angiopoietin concentrations in diabetic retinopathy
-
Patel JI, Hykin PG, Gregor ZJ, Boulton M, Cree IA. Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol 2005; 89(4): 480-483.
-
(2005)
Br J Ophthalmol
, vol.89
, Issue.4
, pp. 480-483
-
-
Patel, J.I.1
Hykin, P.G.2
Gregor, Z.J.3
Boulton, M.4
Cree, I.A.5
-
67
-
-
36549005053
-
Angiopoietinmodulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability
-
Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, et al. Angiopoietinmodulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine 2007; 40(2): 144-150.
-
(2007)
Cytokine
, vol.40
, Issue.2
, pp. 144-150
-
-
Peters, S.1
Cree, I.A.2
Alexander, R.3
Turowski, P.4
Ockrim, Z.5
Patel, J.6
-
68
-
-
76449101742
-
Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia
-
Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, et al. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta diabetologica 2010; 47(1): 59-64.
-
(2010)
Acta Diabetologica
, vol.47
, Issue.1
, pp. 59-64
-
-
Pfister, F.1
Wang, Y.2
Schreiter, K.3
Vom Hagen, F.4
Altvater, K.5
Hoffmann, S.6
-
69
-
-
0033882191
-
Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization
-
Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, et al. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 2000; 184(3): 275-284.
-
(2000)
J Cell Physiol
, vol.184
, Issue.3
, pp. 275-284
-
-
Hackett, S.F.1
Ozaki, H.2
Strauss, R.W.3
Wahlin, K.4
Suri, C.5
Maisonpierre, P.6
-
70
-
-
15044347979
-
Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy
-
Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2005; 139(3): 476-481.
-
(2005)
Am J Ophthalmol
, vol.139
, Issue.3
, pp. 476-481
-
-
Watanabe, D.1
Suzuma, K.2
Suzuma, I.3
Ohashi, H.4
Ojima, T.5
Kurimoto, M.6
-
71
-
-
79955953053
-
A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy
-
Rangasamy S, Srinivasan R, Maestas J, McGuire PG, Das A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52(6): 3784-3791.
-
(2011)
Invest Ophthalmol Vis Sci
, vol.52
, Issue.6
, pp. 3784-3791
-
-
Rangasamy, S.1
Srinivasan, R.2
Maestas, J.3
McGuire, P.G.4
Das, A.5
-
72
-
-
32244436305
-
Angiopoietin-2 sensitizes endothelial cells to TNF-Alpha and has a crucial role in the induction of inflammation
-
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-Alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12(2): 235-239.
-
(2006)
Nat Med
, vol.12
, Issue.2
, pp. 235-239
-
-
Fiedler, U.1
Reiss, Y.2
Scharpfenecker, M.3
Grunow, V.4
Koidl, S.5
Thurston, G.6
-
73
-
-
84989265226
-
Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy
-
You QY, Zhuge FY, Zhu QQ, Si XW. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy. Int J Ophthalmol 2014; 7(4): 648-653.
-
(2014)
Int J Ophthalmol
, vol.7
, Issue.4
, pp. 648-653
-
-
You, Q.Y.1
Zhuge, F.Y.2
Zhu, Q.Q.3
Si, X.W.4
-
74
-
-
9644279384
-
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: Effects of laser photocoagulation and angiotensin receptor blockade
-
Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, et al. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol 2004; 88(12): 1543-1546.
-
(2004)
Br J Ophthalmol
, vol.88
, Issue.12
, pp. 1543-1546
-
-
Lip, P.L.1
Chatterjee, S.2
Caine, G.J.3
Hope-Ross, M.4
Gibson, J.5
Blann, A.D.6
-
75
-
-
0344837347
-
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
-
Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9(3): 294-299.
-
(2003)
Nat Med
, vol.9
, Issue.3
, pp. 294-299
-
-
Hammes, H.P.1
Du, X.2
Edelstein, D.3
Taguchi, T.4
Matsumura, T.5
Ju, Q.6
-
76
-
-
77951939021
-
Protective role of benfotiamine a fat-soluble vitamin B1 analogue in lipopolysaccharide-induced cytotoxic signals in murine macrophages
-
Yadav UC, Kalariya NM, Srivastava SK, Ramana KV. Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages. Free Radic Biol Med 2010; 48(10): 1423-1434.
-
(2010)
Free Radic Biol Med
, vol.48
, Issue.10
, pp. 1423-1434
-
-
Yadav, U.C.1
Kalariya, N.M.2
Srivastava, S.K.3
Ramana, K.V.4
-
77
-
-
84655167299
-
Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages
-
Shoeb M, Ramana KV. Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages. Free Radic Biol Med 2012; 52(1): 182-190.
-
(2012)
Free Radic Biol Med
, vol.52
, Issue.1
, pp. 182-190
-
-
Shoeb, M.1
Ramana, K.V.2
-
78
-
-
0033543751
-
Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting
-
Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ, et al. Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 1999; 274(37): 26523-26528.
-
(1999)
J Biol Chem
, vol.274
, Issue.37
, pp. 26523-26528
-
-
Kim, I.1
Moon, S.O.2
Koh, K.N.3
Kim, H.4
Uhm, C.S.5
Kwak, H.J.6
-
79
-
-
0035860806
-
Angiopoietin-1 unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region
-
Xu Y, Yu Q. Angiopoietin-1 unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001; 276(37): 34990-34998.
-
(2001)
J Biol Chem
, vol.276
, Issue.37
, pp. 34990-34998
-
-
Xu, Y.1
Yu, Q.2
-
80
-
-
0006677050
-
Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway
-
Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res 2000; 86(1): 24-29.
-
(2000)
Circ Res
, vol.86
, Issue.1
, pp. 24-29
-
-
Kim, I.1
Kim, H.G.2
So, J.N.3
Kim, J.H.4
Kwak, H.J.5
Koh, G.Y.6
-
81
-
-
0036095059
-
Suppression of diabetic retinopathy with angiopoietin-1
-
Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002; 160(5): 1683-1693.
-
(2002)
Am J Pathol
, vol.160
, Issue.5
, pp. 1683-1693
-
-
Joussen, A.M.1
Poulaki, V.2
Tsujikawa, A.3
Qin, W.4
Qaum, T.5
Xu, Q.6
-
82
-
-
0035860845
-
Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression
-
Kim I, Moon SO, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001; 89(6): 477-479.
-
(2001)
Circ Res
, vol.89
, Issue.6
, pp. 477-479
-
-
Kim, I.1
Moon, S.O.2
Park, S.K.3
Chae, S.W.4
Koh, G.Y.5
-
83
-
-
84907591751
-
Taurine prevents high glucose-induced angiopoietin-2/tie-2 system alterations and apoptosis in retinal microvascular pericytes
-
Zeng K, Ming J, Yang N, Wang J, Yu X, Song Y, et al. Taurine prevents high glucose-induced angiopoietin-2/tie-2 system alterations and apoptosis in retinal microvascular pericytes. Mol Cell Biochem 2014; 396(1-2): 239-248.
-
(2014)
Mol Cell Biochem
, vol.396
, Issue.1-2
, pp. 239-248
-
-
Zeng, K.1
Ming, J.2
Yang, N.3
Wang, J.4
Yu, X.5
Song, Y.6
-
84
-
-
0034804744
-
From beach to bedside: History of the development of sirolimus
-
Napoli KL, Taylor PJ. From beach to bedside: history of the development of sirolimus. Ther Drug Monit 2001; 23(5): 559-586.
-
(2001)
Ther Drug Monit
, vol.23
, Issue.5
, pp. 559-586
-
-
Napoli, K.L.1
Taylor, P.J.2
-
85
-
-
0034654174
-
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/ phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
-
Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/ phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60(6): 1541-1545.
-
(2000)
Cancer Res
, vol.60
, Issue.6
, pp. 1541-1545
-
-
Zhong, H.1
Chiles, K.2
Feldser, D.3
Laughner, E.4
Hanrahan, C.5
Georgescu, M.M.6
-
86
-
-
0042322315
-
MTOR as a positive regulator of tumor cell responses to hypoxia
-
Abraham RT. mTOR as a positive regulator of tumor cell responses to hypoxia. Curr Top Microbiol Immunol 2004; 279: 299-319.
-
(2004)
Curr Top Microbiol Immunol
, vol.279
, pp. 299-319
-
-
Abraham, R.T.1
-
87
-
-
2942724235
-
MTOR inhibition reverses Aktdependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
-
Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, et al. mTOR inhibition reverses Aktdependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10(6): 594-601.
-
(2004)
Nat Med
, vol.10
, Issue.6
, pp. 594-601
-
-
Majumder, P.K.1
Febbo, P.G.2
Bikoff, R.3
Berger, R.4
Xue, Q.5
McMahon, L.M.6
-
88
-
-
0036789574
-
Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin
-
Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002; 22(20): 7004-7014.
-
(2002)
Mol Cell Biol
, vol.22
, Issue.20
, pp. 7004-7014
-
-
Hudson, C.C.1
Liu, M.2
Chiang, G.G.3
Otterness, D.M.4
Loomis, D.C.5
Kaper, F.6
-
89
-
-
0041920901
-
TSC2 regulates VEGF through mTOR-dependent and-independent pathways
-
Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin Jr. WG TSC2 regulates VEGF through mTOR-dependent and-independent pathways. Cancer cell 2003; 4(2): 147-158.
-
(2003)
Cancer Cell
, vol.4
, Issue.2
, pp. 147-158
-
-
Brugarolas, J.B.1
Vazquez, F.2
Reddy, A.3
Sellers, W.R.4
Kaelin, W.G.5
-
90
-
-
4644239244
-
Mammalian target of rapamycin inhibition
-
Dutcher JP. Mammalian target of rapamycin inhibition. Clin Cancer Res 2004; 10(18 Pt 2): 6382S-6387S.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.18 PT2
, pp. 6382S-6387S
-
-
Dutcher, J.P.1
-
91
-
-
0029769792
-
Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells
-
Rokaw MD, West M, Johnson JP. Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells. J Biol Chem 1996; 271(50): 32468-32473.
-
(1996)
J Biol Chem
, vol.271
, Issue.50
, pp. 32468-32473
-
-
Rokaw, M.D.1
West, M.2
Johnson, J.P.3
-
92
-
-
0033983617
-
Differential anti-inflammatory effects of immunosuppressive drugs: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production
-
Attur MG, Patel R, Thakker G, Vyas P, Levartovsky D, Patel P, et al. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res 2000; 49(1): 20-26.
-
(2000)
Inflamm Res
, vol.49
, Issue.1
, pp. 20-26
-
-
Attur, M.G.1
Patel, R.2
Thakker, G.3
Vyas, P.4
Levartovsky, D.5
Patel, P.6
-
93
-
-
19944432650
-
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty
-
Nuhrenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, et al. Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J 2005; 19(2): 246-248.
-
(2005)
FASEB J
, vol.19
, Issue.2
, pp. 246-248
-
-
Nuhrenberg, T.G.1
Voisard, R.2
Fahlisch, F.3
Rudelius, M.4
Braun, J.5
Gschwend, J.6
-
94
-
-
84855305671
-
A randomized doseescalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema
-
Dugel PU, Blumenkranz MS, Haller JA, Williams GA, Solley WA, Kleinman DM, et al. A randomized, doseescalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema. Ophthalmology 2012; 119(1): 124-131.
-
(2012)
Ophthalmology
, vol.119
, Issue.1
, pp. 124-131
-
-
Dugel, P.U.1
Blumenkranz, M.S.2
Haller, J.A.3
Williams, G.A.4
Solley, W.A.5
Kleinman, D.M.6
-
95
-
-
80755190097
-
Subconjunctival sirolimus in the treatment of diabetic macular edema
-
Krishnadev N, Forooghian F, Cukras C, Wong W, Saligan L, Chew EY, et al. Subconjunctival sirolimus in the treatment of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2011; 249(11): 1627-1633.
-
(2011)
Graefes Arch Clin Exp Ophthalmol
, vol.249
, Issue.11
, pp. 1627-1633
-
-
Krishnadev, N.1
Forooghian, F.2
Cukras, C.3
Wong, W.4
Saligan, L.5
Chew, E.Y.6
-
96
-
-
0029121107
-
Clinically significant macular edema in type i diabetes Incidence and risk factors
-
Vitale S, Maguire MG, Murphy RP, Hiner CJ, Rourke L, Sackett C, et al. Clinically significant macular edema in type I diabetes. Incidence and risk factors. Ophthalmology 1995; 102(8): 1170-1176.
-
(1995)
Ophthalmology
, vol.102
, Issue.8
, pp. 1170-1176
-
-
Vitale, S.1
Maguire, M.G.2
Murphy, R.P.3
Hiner, C.J.4
Rourke, L.5
Sackett, C.6
-
97
-
-
0031944250
-
Molecular architecture of tight junctions
-
Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 1998; 60: 121-142.
-
(1998)
Annu Rev Physiol
, vol.60
, pp. 121-142
-
-
Mitic, L.L.1
Anderson, J.M.2
-
98
-
-
0034912203
-
Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration
-
Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001; 86(1): 308-315.
-
(2001)
Thromb Haemost
, vol.86
, Issue.1
, pp. 308-315
-
-
Dejana, E.1
Spagnuolo, R.2
Bazzoni, G.3
-
99
-
-
29244463365
-
Astrocyte-endothelial interactions at the blood-brain barrier
-
Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7(1): 41-53.
-
(2006)
Nat Rev Neurosci
, vol.7
, Issue.1
, pp. 41-53
-
-
Abbott, N.J.1
Ronnback, L.2
Hansson, E.3
-
100
-
-
12744266491
-
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of bloodretinal and blood-Aqueous barrier breakdown
-
Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of bloodretinal and blood-Aqueous barrier breakdown. Exp Eye Res 2005; 80(2): 249-258.
-
(2005)
Exp Eye Res
, vol.80
, Issue.2
, pp. 249-258
-
-
Edelman, J.L.1
Lutz, D.2
Castro, M.R.3
-
101
-
-
31544476566
-
Glucocorticoid regulation of endothelial cell tight junction gene expression: Novel treatments for diabetic retinopathy
-
Felinski EA, Antonetti DA. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. Curr Eye Res 2005; 30(11): 949-957.
-
(2005)
Curr Eye Res
, vol.30
, Issue.11
, pp. 949-957
-
-
Felinski, E.A.1
Antonetti, D.A.2
-
102
-
-
0031737671
-
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells Penn State Retina Research Group
-
Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998; 47(12): 1953-1959.
-
(1998)
Diabetes
, vol.47
, Issue.12
, pp. 1953-1959
-
-
Antonetti, D.A.1
Barber, A.J.2
Khin, S.3
Lieth, E.4
Tarbell, J.M.5
Gardner, T.W.6
-
103
-
-
33947313405
-
VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability
-
Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 2006; 47(11): 5106-5115.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, Issue.11
, pp. 5106-5115
-
-
Harhaj, N.S.1
Felinski, E.A.2
Wolpert, E.B.3
Sundstrom, J.M.4
Gardner, T.W.5
Antonetti, D.A.6
-
104
-
-
18744362465
-
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier
-
Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 2005; 85(5): 597-607.
-
(2005)
Lab Invest
, vol.85
, Issue.5
, pp. 597-607
-
-
Giebel, S.J.1
Menicucci, G.2
McGuire, P.G.3
Das, A.4
-
105
-
-
68949129005
-
Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability
-
Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 2009; 284(31): 21036-21046.
-
(2009)
J Biol Chem
, vol.284
, Issue.31
, pp. 21036-21046
-
-
Murakami, T.1
Felinski, E.A.2
Antonetti, D.A.3
-
106
-
-
0037401530
-
Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier
-
Saishin Y, Saishin Y, Takahashi K, Melia M, Vinores SA, Campochiaro PA. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier. J Cell Physiol 2003; 195(2): 210-219.
-
(2003)
J Cell Physiol
, vol.195
, Issue.2
, pp. 210-219
-
-
Saishin, Y.1
Saishin, Y.2
Takahashi, K.3
Melia, M.4
Vinores, S.A.5
Campochiaro, P.A.6
-
107
-
-
33751546663
-
Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts
-
Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006; 203(12): 2703-2714.
-
(2006)
J Exp Med
, vol.203
, Issue.12
, pp. 2703-2714
-
-
Orlova, V.V.1
Economopoulou, M.2
Lupu, F.3
Santoso, S.4
Chavakis, T.5
-
108
-
-
34249650761
-
The role of junctional adhesion molecules in vascular inflammation
-
Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007; 7(6): 467-477.
-
(2007)
Nat Rev Immunol
, vol.7
, Issue.6
, pp. 467-477
-
-
Weber, C.1
Fraemohs, L.2
Dejana, E.3
-
109
-
-
0033565947
-
Cutting edge: Combined treatment of TNF-Alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells
-
Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K, et al. Cutting edge: combined treatment of TNF-Alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 1999; 163(2): 553-557.
-
(1999)
J Immunol
, vol.163
, Issue.2
, pp. 553-557
-
-
Ozaki, H.1
Ishii, K.2
Horiuchi, H.3
Arai, H.4
Kawamoto, T.5
Okawa, K.6
-
110
-
-
84896296860
-
The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells
-
Saker S, Stewart EA, Browning AC, Allen CL, Amoaku WM. The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells. Exp Eye Res 2014; 121: 161-167.
-
(2014)
Exp Eye Res
, vol.121
, pp. 161-167
-
-
Saker, S.1
Stewart, E.A.2
Browning, A.C.3
Allen, C.L.4
Amoaku, W.M.5
-
111
-
-
0033895534
-
Retinal and choroidal neovascularization
-
Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000; 184(3): 301-310.
-
(2000)
J Cell Physiol
, vol.184
, Issue.3
, pp. 301-310
-
-
Campochiaro, P.A.1
-
112
-
-
0033774430
-
Microvascular endothelial cells differ in their basal and tumour necrosis factor-Alpha-regulated expression of adhesion molecules and cytokines
-
Lehmann I, Brylla E, Sittig D, Spanel-Borowski K, Aust G. Microvascular endothelial cells differ in their basal and tumour necrosis factor-Alpha-regulated expression of adhesion molecules and cytokines. J Vasc Res 2000; 37(5): 408-416.
-
(2000)
J Vasc Res
, vol.37
, Issue.5
, pp. 408-416
-
-
Lehmann, I.1
Brylla, E.2
Sittig, D.3
Spanel-Borowski, K.4
Aust, G.5
-
113
-
-
0030890905
-
Central nervous system complications of diabetes mellitus-A perspective from the bloodbrain barrier
-
Mooradian AD. Central nervous system complications of diabetes mellitus-A perspective from the bloodbrain barrier. Brain Res Brain Res Rev 1997; 23(3): 210-218.
-
(1997)
Brain Res Brain Res Rev
, vol.23
, Issue.3
, pp. 210-218
-
-
Mooradian, A.D.1
-
114
-
-
0036115848
-
Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: Effect of antidiabetic medicines
-
Omi H, Okayama N, Shimizu M, Okouchi M, Ito S, Fukutomi T, et al. Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. J Diabetes Complications 2002; 16(3): 201-208.
-
(2002)
J Diabetes Complications
, vol.16
, Issue.3
, pp. 201-208
-
-
Omi, H.1
Okayama, N.2
Shimizu, M.3
Okouchi, M.4
Ito, S.5
Fukutomi, T.6
-
115
-
-
0032080628
-
Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion
-
Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998; 101(9): 1905-1915.
-
(1998)
J Clin Invest
, vol.101
, Issue.9
, pp. 1905-1915
-
-
Morigi, M.1
Angioletti, S.2
Imberti, B.3
Donadelli, R.4
Micheletti, G.5
Figliuzzi, M.6
-
116
-
-
0036316767
-
Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo
-
Booth G, Stalker TJ, Lefer AM, Scalia R. Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes 2002; 51(5): 1556-1564.
-
(2002)
Diabetes
, vol.51
, Issue.5
, pp. 1556-1564
-
-
Booth, G.1
Stalker, T.J.2
Lefer, A.M.3
Scalia, R.4
-
117
-
-
0029127230
-
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
-
Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376(6540): 517-519.
-
(1995)
Nature
, vol.376
, Issue.6540
, pp. 517-519
-
-
Koch, A.E.1
Halloran, M.M.2
Haskell, C.J.3
Shah, M.R.4
Polverini, P.J.5
-
118
-
-
0032988651
-
VEGF increases retinal vascular ICAM-1 expression in vivo
-
Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 1999; 40(8): 1808-1812.
-
(1999)
Invest Ophthalmol Vis Sci
, vol.40
, Issue.8
, pp. 1808-1812
-
-
Lu, M.1
Perez, V.L.2
Ma, N.3
Miyamoto, K.4
Peng, H.B.5
Liao, J.K.6
-
119
-
-
77949537099
-
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases
-
Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009; 4(12): e8158.
-
(2009)
PLoS One
, vol.4
, Issue.12
, pp. e8158
-
-
Yoshimura, T.1
Sonoda, K.H.2
Sugahara, M.3
Mochizuki, Y.4
Enaida, H.5
Oshima, Y.6
-
120
-
-
0036207489
-
And vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders
-
Funatsu H, Yamashita H, Ikeda T, Nakanishi Y, Kitano S, Hori S. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 2002; 133(4): 537-543.
-
(2002)
Am J Ophthalmol
, vol.133
, Issue.4
, pp. 537-543
-
-
Funatsu, H.1
Yamashita, H.2
Ikeda, T.3
Nakanishi, Y.4
Kitano, S.5
Hori, S.6
Angiotensin, I.I.7
-
121
-
-
18244372934
-
Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema
-
Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 2005; 112(5): 806-816.
-
(2005)
Ophthalmology
, vol.112
, Issue.5
, pp. 806-816
-
-
Funatsu, H.1
Yamashita, H.2
Sakata, K.3
Noma, H.4
Mimura, T.5
Suzuki, M.6
-
122
-
-
0034790850
-
Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy
-
Funatsu H, Yamashita H, Shimizu E, Kojima R, Hori S. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 2001; 21(5): 469-477.
-
(2001)
Retina
, vol.21
, Issue.5
, pp. 469-477
-
-
Funatsu, H.1
Yamashita, H.2
Shimizu, E.3
Kojima, R.4
Hori, S.5
-
123
-
-
34247098288
-
Leukocytes in diabetic retinopathy
-
Chibber R, Ben-Mahmud BM, Chibber S, Kohner EM. Leukocytes in diabetic retinopathy. Curr Diabetes Rev 2007; 3(1): 3-14.
-
(2007)
Curr Diabetes Rev
, vol.3
, Issue.1
, pp. 3-14
-
-
Chibber, R.1
Ben-Mahmud, B.M.2
Chibber, S.3
Kohner, E.M.4
-
124
-
-
0033820619
-
Activity of the glycosylating enzyme 6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with agematched control subjects: Relevance to capillary occlusion in diabetic retinopathy Core 2 GlcNAc (beta1
-
Chibber R, Ben-Mahmud BM, Coppini D, Christ E, Kohner EM. Activity of the glycosylating enzyme, core 2 GlcNAc (beta1, 6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with agematched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes 2000; 49(10): 1724-1730.
-
(2000)
Diabetes
, vol.49
, Issue.10
, pp. 1724-1730
-
-
Chibber, R.1
Ben-Mahmud, B.M.2
Coppini, D.3
Christ, E.4
Kohner, E.M.5
-
125
-
-
0038321279
-
Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: A mechanism underlying capillary occlusion in diabetic retinopathy
-
Chibber R, Ben-Mahmud BM, Mann GE, Zhang JJ, Kohner EM. Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes 2003; 52(6): 1519-1527.
-
(2003)
Diabetes
, vol.52
, Issue.6
, pp. 1519-1527
-
-
Chibber, R.1
Ben-Mahmud, B.M.2
Mann, G.E.3
Zhang, J.J.4
Kohner, E.M.5
-
126
-
-
44649186476
-
Dexamethasone inhibits high glucose-, TNF-Alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes
-
Nehme A, Edelman J. Dexamethasone inhibits high glucose-, TNF-Alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci 2008; 49(5): 2030-2038.
-
(2008)
Invest Ophthalmol Vis Sci
, vol.49
, Issue.5
, pp. 2030-2038
-
-
Nehme, A.1
Edelman, J.2
-
127
-
-
77955829610
-
The multifactorial nature of retinal vascular disease
-
Kleinman ME, Baffi JZ, Ambati J. The multifactorial nature of retinal vascular disease. Ophthalmologica 2010; 224(Suppl 1): 16-24.
-
(2010)
Ophthalmologica
, vol.224
, pp. 16-24
-
-
Kleinman, M.E.1
Baffi, J.Z.2
Ambati, J.3
-
128
-
-
44649151676
-
Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element
-
Felinski EA, Cox AE, Phillips BE, Antonetti DA. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 2008; 86(6): 867-878.
-
(2008)
Exp Eye Res
, vol.86
, Issue.6
, pp. 867-878
-
-
Felinski, E.A.1
Cox, A.E.2
Phillips, B.E.3
Antonetti, D.A.4
-
129
-
-
85017733285
-
The functional effects and expression of HGF and FGF in the choroid
-
Stewart EA, Amoaku WM. The functional effects and expression of HGF and FGF in the choroid. Acta Ophthalmol 2014; 92: s293.
-
(2014)
Acta Ophthalmol
, vol.92
, pp. s293
-
-
Stewart, E.A.1
Amoaku, W.M.2
-
130
-
-
57949095207
-
Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema
-
Roh MI, Kim HS, Song JH, Lim JB, Kwon OW. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 2009; 116(1): 80-86.
-
(2009)
Ophthalmology
, vol.116
, Issue.1
, pp. 80-86
-
-
Roh, M.I.1
Kim, H.S.2
Song, J.H.3
Lim, J.B.4
Kwon, O.W.5
-
131
-
-
78049283701
-
Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab
-
Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, et al. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010; 30(9): 1412-1419.
-
(2010)
Retina
, vol.30
, Issue.9
, pp. 1412-1419
-
-
Funk, M.1
Schmidinger, G.2
Maar, N.3
Bolz, M.4
Benesch, T.5
Zlabinger, G.J.6
-
132
-
-
80053322513
-
Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema
-
Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 2011; 152(4): 686-694.
-
(2011)
Am J Ophthalmol
, vol.152
, Issue.4
, pp. 686-694
-
-
Sohn, H.J.1
Han, D.H.2
Kim, I.T.3
Oh, I.K.4
Kim, K.H.5
Lee, D.Y.6
-
133
-
-
70349243143
-
The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy
-
Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2009; 127(9): 1175-1182.
-
(2009)
Arch Ophthalmol
, vol.127
, Issue.9
, pp. 1175-1182
-
-
Klein, B.E.1
Knudtson, M.D.2
Tsai, M.Y.3
Klein, R.4
-
134
-
-
41349107607
-
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; A placebo-controlled, randomized clinical trial
-
Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, et al. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2008; 246(4): 483-489.
-
(2008)
Graefes Arch Clin Exp Ophthalmol
, vol.246
, Issue.4
, pp. 483-489
-
-
Ahmadieh, H.1
Ramezani, A.2
Shoeibi, N.3
Bijanzadeh, B.4
Tabatabaei, A.5
Azarmina, M.6
-
135
-
-
84856598999
-
Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema
-
Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina 2012; 32(2): 314-321.
-
(2012)
Retina
, vol.32
, Issue.2
, pp. 314-321
-
-
Soheilian, M.1
Garfami, K.H.2
Ramezani, A.3
Yaseri, M.4
Peyman, G.A.5
-
136
-
-
36749103212
-
Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema
-
Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, et al. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 2007; 27(9): 1187-1195.
-
(2007)
Retina
, vol.27
, Issue.9
, pp. 1187-1195
-
-
Soheilian, M.1
Ramezani, A.2
Bijanzadeh, B.3
Yaseri, M.4
Ahmadieh, H.5
Dehghan, M.H.6
-
137
-
-
58149374861
-
Intravitreal bevacizumab versus combined bevacizumab-Triamcinolone versus macular laser photocoagulation in diabetic macular edema
-
Faghihi H, Roohipoor R, Mohammadi SF, Hojat-Jalali K, Mirshahi A, Lashay A, et al. Intravitreal bevacizumab versus combined bevacizumab-Triamcinolone versus macular laser photocoagulation in diabetic macular edema. Eur J Ophthalmol 2008; 18(6): 941-948.
-
(2008)
Eur J Ophthalmol
, vol.18
, Issue.6
, pp. 941-948
-
-
Faghihi, H.1
Roohipoor, R.2
Mohammadi, S.F.3
Hojat-Jalali, K.4
Mirshahi, A.5
Lashay, A.6
-
138
-
-
67349168190
-
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema
-
Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009; 116(6): 1142-1150.
-
(2009)
Ophthalmology
, vol.116
, Issue.6
, pp. 1142-1150
-
-
Soheilian, M.1
Ramezani, A.2
Obudi, A.3
Bijanzadeh, B.4
Salehipour, M.5
Yaseri, M.6
-
139
-
-
80053563597
-
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema
-
Sheth S, Rush R, Natarajan S, Gillies M. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema. Clin Experiment Ophthalmol 2011; 39(7): 673-681.
-
(2011)
Clin Experiment Ophthalmol
, vol.39
, Issue.7
, pp. 673-681
-
-
Sheth, S.1
Rush, R.2
Natarajan, S.3
Gillies, M.4
-
140
-
-
84883775340
-
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema
-
Callanan DG, Gupta S, Boyer DS, Ciulla TA, Singer MA, Kuppermann BD, et al. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology 2013; 120(9): 1843-1851.
-
(2013)
Ophthalmology
, vol.120
, Issue.9
, pp. 1843-1851
-
-
Callanan, D.G.1
Gupta, S.2
Boyer, D.S.3
Ciulla, T.A.4
Singer, M.A.5
Kuppermann, B.D.6
-
141
-
-
77953530014
-
Combined inhibition of platelet derived (pdgf) and vascular endothelial (vegf) growth factors for the treatment of neovascular age-related macular degeneration (nv-Amd)-results of a phase 1 study
-
Ophthotech Anti-PDGF in AMD Study Group.
-
Boyer DS, Ophthotech Anti-PDGF in AMD Study Group. Combined Inhibition of Platelet Derived (PDGF) and Vascular Endothelial (VEGF) Growth Factors for the Treatment of Neovascular Age-Related Macular Degeneration (NV-AMD)-Results of a Phase 1 Study. ARVO Meet Abst 2009; 50(5): 1260.
-
(2009)
ARVO Meet Abst
, vol.50
, Issue.5
, pp. 1260
-
-
Boyer, D.S.1
-
142
-
-
84896699328
-
Systemic upregulation of PDGF-B in patients with neovascular AMD
-
Zehetner C, Kirchmair R, Neururer SB, Kralinger MT, Bechrakis NE, Kieselbach GF. Systemic upregulation of PDGF-B in patients with neovascular AMD. Invest Ophthalmol Vis Sci 2014; 55(1): 337-344.
-
(2014)
Invest Ophthalmol Vis Sci
, vol.55
, Issue.1
, pp. 337-344
-
-
Zehetner, C.1
Kirchmair, R.2
Neururer, S.B.3
Kralinger, M.T.4
Bechrakis, N.E.5
Kieselbach, G.F.6
-
143
-
-
84859030420
-
Global prevalence and major risk factors of diabetic retinopathy
-
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35(3): 556-564.
-
(2012)
Diabetes Care
, vol.35
, Issue.3
, pp. 556-564
-
-
Yau, J.W.1
Rogers, S.L.2
Kawasaki, R.3
Lamoureux, E.L.4
Kowalski, J.W.5
Bek, T.6
-
144
-
-
77954654472
-
Effects of medical therapies on retinopathy progression in type 2 diabetes
-
Group AS, Group AES, Chew EY, Ambrosius WT, Davis MD, Danis RP, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363(3): 233-244.
-
(2010)
N Engl J Med
, vol.363
, Issue.3
, pp. 233-244
-
-
Group, A.S.1
Group, A.E.S.2
Chew, E.Y.3
Ambrosius, W.T.4
Davis, M.D.5
Danis, R.P.6
-
145
-
-
79960462692
-
Medical management of diabetic retinopathy: Fenofibrate and ACCORD Eye studies
-
Wright AD, Dodson PM. Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies. Eye (Lond) 2011; 25(7): 843-849.
-
(2011)
Eye (Lond
, vol.25
, Issue.7
, pp. 843-849
-
-
Wright, A.D.1
Dodson, P.M.2
-
146
-
-
84857425212
-
Prevention and treatment of diabetic retinopathy: Evidence from large, randomized trials the emerging role of fenofibrate
-
Simo R, Hernandez C. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate. Rev Recent Clin Trials 2012; 7(1): 71-80.
-
(2012)
Rev Recent Clin Trials
, vol.7
, Issue.1
, pp. 71-80
-
-
Simo, R.1
Hernandez, C.2
|